Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure

NCT01156636 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Diastolic Heart Failure

Interventions

DRUG: Sildenafil
DRUG: Placebo

Sponsor

University of Milan